Elanco Animal Health Incorporated

Financials

Overview Estratto Conto Statistics Dividends

Cash from operating activities 41 M483 M452 M271 M541 M560 M 560 M Cash from investing activities 4.78 B530 M179 M169 M1.16 B279 M 279 M Cash from financing activities 4.95 B210 M549 M83 M1.49 B275 M 275 M Free cash flow -269.9 M286 M268 M117 M380 M284 M 284 M

Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company, before being divested. It is the third-largest animal health company in the world.

ELAN

Financials

Elanco Animal Health Incorporated

Notizie

Elanco Animal Health Incorporated (ELAN) Presents at BofA Securities Animal Health Summit Transcript

Elanco al Summit di BofA Securities: focus sulla crescita strategica

Elanco at BofA Securities Summit: Strategic Growth in Focus

KeyBanc alza il target su Elanco Animal Health per forza prodotti

KeyBanc raises Elanco Animal Health price target on product strength

BofA alza il target su Elanco Animal Health per le prospettive di crescita

BofA raises Elanco Animal Health stock price target on growth outlook

AMD, IBM among market cap stock movers on Tuesday

Le azioni di Elanco Animal Health raggiungono il massimo di 52 settimane a 26,09 USD

Elanco Animal Health stock hits 52-week high at 26.09 USD

Elanco Q4 2025 slides: innovation drives growth, debt falls faster

Elanco Animal Health Incorporated (ELAN) Q4 Earnings and Revenues Surpass Estimates